Regenerex Pharma (RGPX) Total Liabilities (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Total Liabilities data on file, last reported at $5.3 million in Q3 2025.

• Total Liabilities for Q3 2025 came in at $5.3 million, down 1.36% year-over-year; the trailing twelve-month figure through Sep 2025 was $5.3 million (down 1.36% YoY), and the FY2025 annual result was $5.4 million, up 12.24% from the prior year.
• Total Liabilities held at $5.3 million in Q3 2025 per RGPX's latest filing, from $5.3 million in the prior quarter.
• Over five years, Total Liabilities peaked at $5.7 million in Q4 2024 and troughed at $845496.0 in Q1 2021.
• A 5-year average of $3.0 million and a median of $2.1 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities jumped 340.72% in 2023, then dropped 1.36% in 2025.
• A 5-year view of Total Liabilities shows it stood at $948583.0 in 2021, then gained by 14.55% to $1.1 million in 2022, then surged by 335.14% to $4.7 million in 2023, then rose by 20.57% to $5.7 million in 2024, then fell by 6.74% to $5.3 million in 2025.
• Business Quant data shows RGPX's Total Liabilities at $5.3 million in Q3 2025, $5.3 million in Q2 2025, and $5.4 million in Q1 2025.